Thompson, A and Veal, F, Ensuring the PBS remains optimally fit for purpose - the need for improved retrospective review of listing decisions, National Medicines Symposium, 19-20 May, Canberra, Australia (2016) [Conference Extract]
The Pharmaceutical Benefits Scheme (PBS) is a key component of Australia's National Medicines Policy (NMP), the aims of which are to achieve 'optimal health outcomes and economic objectives'.
While the scheme generally achieves these aims, the PBS status of some well-established medicines currently prevents subsidised access to clinically and cost-effective treatments, conflicting with the aims of the NMP.
|Item Type:||Conference Extract|
|Keywords:||Pharmaceutical Benefits Scheme, pain, gabapentinoids|
|Research Division:||Biomedical and Clinical Sciences|
|Research Group:||Pharmacology and pharmaceutical sciences|
|Research Field:||Clinical pharmacy and pharmacy practice|
|Objective Group:||Evaluation of health and support services|
|Objective Field:||Health policy evaluation|
|UTAS Author:||Thompson, A (Mr Angus Thompson)|
|UTAS Author:||Veal, F (Dr Felicity Veal)|
Repository Staff Only: item control page